Towards an HIV cure: a global scientific strategy Nature reviews Immunology 12 (8), 607-614, 2012 | 606 | 2012 |
A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo M Markowitz, M Louie, A Hurley, E Sun, M Di Mascio, AS Perelson, DD Ho Journal of virology 77 (8), 5037-5038, 2003 | 441 | 2003 |
SB 242 084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system V Di Matteo, G Di Giovanni, M Di Mascio, E Esposito Neuropharmacology 38 (8), 1195-1205, 1999 | 319 | 1999 |
Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study G Di Giovanni, P De Deurwaerdère, M Di Mascio, V Di Matteo, E Esposito, ... Neuroscience 91 (2), 587-597, 1999 | 261 | 1999 |
Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin2C/2B receptor agonists: a combined in vivo electrophysiological and … G Di Giovanni, V Di Matteo, M Di Mascio, E Esposito Synapse 35 (1), 53-61, 2000 | 239 | 2000 |
Evaluation of the most intense high-intensity running period in English FA premier league soccer matches M Di Mascio, PS Bradley The Journal of Strength & Conditioning Research 27 (4), 909-915, 2013 | 215 | 2013 |
Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin2C receptors V Di Matteo, G Di Giovanni, M Di Mascio, E Esposito Brain research 865 (1), 85-90, 2000 | 207 | 2000 |
Effects of in Vivo Cd8+ T Cell Depletion on Virus Replication in Rhesus Macaques Immunized with a Live, Attenuated Simian Immunodeficiency Virus Vaccine KJ Metzner, X Jin, FV Lee, A Gettie, DE Bauer, M Di Mascio, AS Perelson, ... The Journal of experimental medicine 191 (11), 1921-1932, 2000 | 191 | 2000 |
HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells M Catalfamo, M Di Mascio, Z Hu, S Srinivasula, V Thaker, J Adelsberger, ... Proceedings of the National Academy of Sciences 105 (50), 19851-19856, 2008 | 178 | 2008 |
Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques HY Chen, M Di Mascio, AS Perelson, DD Ho, L Zhang Proceedings of the National Academy of Sciences 104 (48), 19079-19084, 2007 | 176 | 2007 |
Elite suppressors harbor low levels of integrated HIV DNA and high levels of 2-LTR circular HIV DNA compared to HIV+ patients on and off HAART EH Graf, AM Mexas, JJ Yu, F Shaheen, MK Liszewski, M Di Mascio, ... PLoS pathogens 7 (2), e1001300, 2011 | 160 | 2011 |
Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients JA Kovacs, RA Lempicki, IA Sidorov, JW Adelsberger, I Sereti, W Sachau, ... The Journal of clinical investigation 115 (8), 2139-2148, 2005 | 159 | 2005 |
Selective blockade of serotonin2C/2B receptors enhances dopamine release in the rat nucleus accumbens V Di Matteo, G Di Giovanni, M Di Mascio, E Esposito Neuropharmacology 37 (2), 265-272, 1998 | 157 | 1998 |
Selective serotonin reuptake inhibitors reduce the spontaneous activity of dopaminergic neurons in the ventral tegmental area M Di Mascio, G Di Giovanni, V Di Matteo, S Prisco, E Esposito Brain research bulletin 46 (6), 547-554, 1998 | 128 | 1998 |
Viral blip dynamics during highly active antiretroviral therapy M Di Mascio, M Markowitz, M Louie, C Hogan, A Hurley, C Chung, DD Ho, ... Journal of virology 77 (22), 12165-12172, 2003 | 120 | 2003 |
Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials AM Mexas, EH Graf, MJ Pace, JY Jianqing, E Papasavvas, L Azzoni, ... Aids 26 (18), 2295-2306, 2012 | 109 | 2012 |
Determining the relative efficacy of highly active antiretroviral therapy M Louie, C Hogan, M Di Mascio, A Hurley, V Simon, J Rooney, N Ruiz, ... The Journal of infectious diseases 187 (6), 896-900, 2003 | 107 | 2003 |
Determining the antiviral activity of tenofovir disoproxil fumarate in treatment-naive chronically HIV-1-infected individuals M Louie, C Hogan, A Hurley, V Simon, C Chung, N Padte, P Lamy, ... Aids 17 (8), 1151-1156, 2003 | 103 | 2003 |
Naive T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell … M Di Mascio, I Sereti, LT Matthews, V Natarajan, J Adelsberger, ... Journal of virology 80 (6), 2665-2674, 2006 | 81 | 2006 |
Modeling the long-term control of viremia in HIV-1 infected patients treated with antiretroviral therapy M Di Mascio, RM Ribeiro, M Markowitz, DD Ho, AS Perelson Mathematical biosciences 188 (1-2), 47-62, 2004 | 76 | 2004 |